Navigating MHRA Guidelines & Clinical Trial Regulations for CAR & TCR Therapies

• Clarify the latest MHRA regulations shaping CAR-T and TCR-T therapy development, including decentralized manufacturing and personalized treatment pathways to accelerate patient access to safe, specialized therapies
• Outline approaches to documentation, engagement, and compliance that support smooth regulatory interactions
• Evaluate the impact of MRHA legislation on CAR and TCR therapy trials

Speakers:

Kingyin Lee

Head of Clinical Trials

MHRA